CD8A and neoplasm: EVs from an antigen-loaded DC bearing tumor antigens that may promote CD4+ and CD8+ T cell responses by direct antigen presentation, which leads to tumor growth suppression [35,36,52] with increased efficiency in the case of mature DC-derived EVs [39].